"
Team:Purdue/Notebook
From 2009.igem.org
| Line 32: | Line 32: | ||
''July 21st, 2009'' The team recieved the BV-2 line from Harvard Medical School. Thanks again to Dr. Selkoe and Beth Ostaszewski for providing the line. We immediately plated the cells and will be checking on them in four hours. Our offical lab notebook has been started. We hope to get our glioblastoma line in this week or next. | ''July 21st, 2009'' The team recieved the BV-2 line from Harvard Medical School. Thanks again to Dr. Selkoe and Beth Ostaszewski for providing the line. We immediately plated the cells and will be checking on them in four hours. Our offical lab notebook has been started. We hope to get our glioblastoma line in this week or next. | ||
| - | ''July 22nd, 2009'' Upon hearing the bad news that the glioblastoma line we were to recieve from Dr. Yu was completely gone | + | ''July 22nd, 2009'' Upon hearing the bad news that the glioblastoma line we were to recieve from Dr. Yu was completely gone, we researched papers looking for similar reagents used by other groups. Dr. Tofilon, from the Moffitt Cancer Center in Florida, has generously agreed to provide us with a vial of >90% CD133 cells. We are incredibly grateful to Dr. Tofilon and his students. We hope to have the rest of the media supply in by next week, and then recieve and begin working with the cells. |
''July 23rd, 2009'' We have begun to grow up our BV-2s so that we can freeze them down. So far... so good. We hope to have our designed constructs done in two weeks and send them off to gene art. An expression vector has been picked out. | ''July 23rd, 2009'' We have begun to grow up our BV-2s so that we can freeze them down. So far... so good. We hope to have our designed constructs done in two weeks and send them off to gene art. An expression vector has been picked out. | ||
Revision as of 14:21, 17 September 2009
Home The Team The Project Parts Submitted to the Registry Modeling Notebook
Purdue Team Notebook
From May 6th - June 17th of 2009 The team researched possible topics. We knew we wanted to focus on cancer, but had to start from the beginning by researching as much as could before deciding on a final approach.
June 17th, 2009 Team has decided to focus on engineering microglia to recognize and label/destroy glioblastoma stem-like cancer cells.
June 18th - 23rd, 2009 The team has begun to search for reviews on microglia cells and to find potential markers for glioblastoma stem-like cancer cells.
June 24th, 2009 We have decided to use BV-2 microglial cell line. Have begun to search for labs in America that are using it to have a less expensive shipping cost. Also, created a gant chart. This will allow us to stay on top of our project, assess and meet our goals, and keep team members responsible for being apart of the project.
June 25th, 2009 Dr. Selkoe, from Harvard Medical School, has agreed to send us a sample of BV-2 cells. We are working to secure the correct media needed for both microglia and glioblastoma cells.
June 26th, 2009 The team has decided to meet on Fridays as well as Wednesdays to allow for more face-to-face communication.
June 29th, 2009 Today the team is having its first cell-culture meeting to prepare for working with mammalian cells. Today, we will send Dr. Selkoe our information to recieve the BV-2 line.
June 30th, 2009 The team will recieve a glioblastoma line from Dr. Yu who works with Cedars-Sinai Medical Center. We are meeting with a graduate student here at the university to discuss 3D culture.
July 1st - 20th, 2009 The team has been researching, buying media, finding protocols, and waiting for our cell lines to come in. Have begun inital designs of acutal constructs. Have chosen to go with two.
July 21st, 2009 The team recieved the BV-2 line from Harvard Medical School. Thanks again to Dr. Selkoe and Beth Ostaszewski for providing the line. We immediately plated the cells and will be checking on them in four hours. Our offical lab notebook has been started. We hope to get our glioblastoma line in this week or next.
July 22nd, 2009 Upon hearing the bad news that the glioblastoma line we were to recieve from Dr. Yu was completely gone, we researched papers looking for similar reagents used by other groups. Dr. Tofilon, from the Moffitt Cancer Center in Florida, has generously agreed to provide us with a vial of >90% CD133 cells. We are incredibly grateful to Dr. Tofilon and his students. We hope to have the rest of the media supply in by next week, and then recieve and begin working with the cells.
July 23rd, 2009 We have begun to grow up our BV-2s so that we can freeze them down. So far... so good. We hope to have our designed constructs done in two weeks and send them off to gene art. An expression vector has been picked out.
